Introduction
Non-adherence to medication therapy is a worldwide problem by reducing the therapeutic results, especially chronic diseases, and increasing the costs of health systems (1) .
Conceptually, non-adherence should be assumed as a multi-dimensional construct. It is related not only to medication intake or not, but to how the patients "manage" their treatment: behavior in relation to dose, time, frequency and duration (2) . Few studies in Brazil and around the world describe the adherence rates among hypertensive patients, especially in rural areas. Most investigations have been focused on the evaluation in urban centers and these data cannot be extended to rural areas, as populations have very different demographic characteristics, food and cultural habits, occupation types and access to health care (3) .
The literature shows that the prevalence of non-adherence of people with Systemic Arterial Hypertension (SAH) to medication treatment is quite varied (4) . Research conducted with hypertensive patients in outpatient clinics of Brazilian hospitals showed a percentage of non-adherence of 86.7% in São José do Rio Preto (SP) (5) and 12.7% in Ribeirão
Preto (SP) (6) . In the primary care of a small town in Rio Grande do Sul, the non-adherence rate was 34.3% (7) . In Teresina (PI), non-adherence was 26.8% (8) and, in Maringá (PR), it was equal to 64.0% (9) .
Studies in rural areas of different countries have also shown varying rates of non-adherence to medication treatment for SAH. Rates of 66.0% in Turkey (10) and 60.1% in the United States (11) were found. In Brazil, a study conducted in the state of Minas Gerais showed non-adherence rate of 28% (12) .
The world report shows that this variability in the frequency of adherence depends on the method used for its estimation, population characteristics investigated and the sample size (1) .
Regarding the factors that influence treatment adherence, researchers point out multiple causes, i.e.
adherence depends on the disease (chronicity, absence of symptoms and late consequences), treatment (medication consumed), characteristics and beliefs of people (gender, age, ethnicity, marital status, education and socio-economic status), life habits, cultural aspects (lack of perception of the seriousness of the disease, ignorance, illness in the family context and self-esteem) and how people with SAH relate with the health service (1) .
Thus, given the diversity of contexts between residents of urban and rural areas, this study aims to evaluate the indexes and the main factors associated with non-adherence to medication treatment for SAH between urban and rural areas of a Brazilian city.
Method
The study was conducted in a city located in the (13) . (14) . Individuals were selected through random sampling that included 5,933 adult inhabitants resident in rural and urban areas, with correction for finite populations and adjustment for a refusal population of 20%, respecting the population density of each area.
The confidence interval was set as 95% and the design error as 2.5%.
For each area covered by the FHS teams, a sample corresponding to 563 participants from urban and 153 from rural areas was estimated. For the data collection procedure, a sample draw was performed in four stages.
The sampling units of the first stage were carried out according to the FHP coverage areas of urban and rural regions of the municipality.
In the urban area, the second stage comprised sampling by street, the third by residences, and the fourth by choosing a resident. To maintain and Classification of Brazil according to the Associação Brasileira de Empresas de Pesquisa (15) , which takes education and consumer goods for reference, where the variation occurs between Class A, which is the best stratum, up to class E, with the most unfavorable conditions); sedentary lifestyle (not performing physical activity at least three times/week for at least 30 minutes/day); smoking (consumption of at least one cigarette/day); alcohol consumption (consumption of more than 30 g of ethanol/day for men and 15g/day for women) (14) ; time of diagnosis of SAH (up to 3 years or ≥ 3 years), according to criteria adopted by the authors of the non-adherence measurement instrument used in this study (16) ; difficulty to access the health services;
type of health service used (health insurance/private or SUS); reason why the health service was searched (only in emergency cases, for routine consultationsat least one medical visit every six months (14) -or to get medications) and amount of anti-hypertensive pills prescribed a day.
For the assessment of non-adherence to treatment of SAH, the instrument "Questionnaire of Adherence to
Medications -Qualiaids" (QAM-Q) was used, developed and validated in Brazil (2) . The questionnaire was developed to address the act (if the individual takes and how much medication is taken), the process (such as how medication is taken in seven days, if he/she skips, if he/she takes it abnormally, if he/she has "breaks") and the adherence results (in this case, if his/her pressure was under control).
To sort the interviewee as non-adherent a composite measure was constructed, in which the presence of one of these conditions was sufficient:
either not taking the correct amount (80% -120% of the prescribed doses), or not taking it the right way (without "breaks", "erratic intake", abandonment or "partial adherence"), or to report that his/her blood pressure was altered (2) .
To analyze the association between the dependent 
Results
The prevalence of non-adherence to medication treatment of SAH as a combined measure of QAM-Q Tables 1 and 2 . 
Discussion
The rate of non-adherence to SAH treatment presented in this work is within the percentage limits reported in other studies conducted in Brazil (2, 5, (7) (8) (9) .
Among the three non-adherence measurement parameters used by the QAM-Q instrument, our findings indicate that the process of taking medication was the main responsible for non-adherence to treatment among hypertensive patients in the rural area; in the urban population, it was highlighted the "treatment result". In the rural area, there was a prevalence of younger people who use more than three pills a day.
However, the percentages related to socio-demographic characteristics, economic, clinical, related to lifestyle and access to health care may be more significant for both populations (Tables 1 and 2 ).
Both in rural and in urban areas, more than half of the hypertensive patients did not adhere to the medication treatment of SAH. A difference of about seven percentage points between adherence rates was observed though, especially in urban areas. In line with our results, a study conducted in the State of Minas Gerais (Brazil) found a rate of non-adherence to medication treatment of SAH six percent higher in the urban area compared to the rural area (12) . Some researchers believe that the fact can be attributed to the influence of socio-economic and cultural aspects (17) .
All six variables that are statistically associated with non-adherence (male, age up to 59 years old, low economic status, alcohol consumption, shorter time of SAH and reason for seeking the health service -only in emergencies) showed higher prevalence among hypertensive patients living in the urban area (Tables   3 and 4 ).
Our findings indicated that hypertensive females adhered more to treatment in both urban and rural areas. The males showed a risk of non-adherence 1.95
higher when compared to women, with a statistically significant difference (Table 3) . Studies have pointed out that women perceive and report their health problems more obstinately than men, and that they seek health services more often and therefore follow the prescription better (16) .
In terms of age, several studies have also shown poor adherence among non-elderly (9, 14, 18) , both in rural and urban areas, where people 20-59 years old had 2.51 times higher risk of not adhering to drug treatment than participants of 60 years old or older. It has been argued that the characteristic of asymptomatic SAH can cause certain indifference in younger people regarding the control of the disease, increasing the risks of severe complications and mortality by cardiovascular disease (9) .
We also found that individuals with lower economic status, belonging to economic status C, D or E, showed a risk of 1.95 higher of non-adherence to treatment, compared to those in status A or B. This event has already been reported by other researchers (2, 18) , according to whom the socio-economic situation strongly influences the adherence, and are related not only to the purchasing power of medication, but also to educational, cultural and social aspects (2) .
Although some investigations have found that, the higher the education degree, the higher will be the level of adherence to medication treatment (10, 19) , in this study we did not observe this relationship. analyze the reasons that lead patients to non-adherence to treatment of SAH (20) .
Differently than stated in the literature, which argues that a high number of medicines used tends to decrease adherence (16, 21) , our results did not show association between polypharmacy and adherence to medication treatment of SAH.
These research data indicate that hypertensive individuals with less time of diagnosis of SAH (up to three years) had higher non-adherence rates than those with longer time (over three years) ( Table 4) .
The results of another study with hypertensive people reiterate that, the shorter the duration of the disease and pharmacological treatment, the higher the nonadherence rate (16) . According to the hypertensive patients who composed our sample, the "absence of symptoms" was the main reason for non-adherence to medication treatment, both in rural and urban areas. For many researchers (10, 16) , asymptomatic characteristic of the disease and the need for lifelong treatment are remarkable events that contribute to non-adherence to treatment. A study (22) conducted with 353 patients at a University Hospital in the state of São Paulo pointed out that the asymptomatic nature of SAH contributed to 36% of non-adherence.
We also found that the majority of the population, both in urban and rural areas, reported using the Brazilian Unified Health System (SUS). The difficulty of access to health care was mentioned by participants in both areas, but prevailed among the residents of rural areas, for whom the distance to be covered is the element that contributes imperatively to this restriction. Those attending the service for routine consultations adhered more to treatment than those who visited the service only to get medications or in case of emergencies, both in rural as in urban areas (Table 4) .
The attendance to appointments is crucial for the control of hypertension, because it brings individual motivation and this, in turn, leads to certain attitudes that favor the reduction of blood pressure, and adherence to medication treatment (5) . A study of 245 hypertensive patients in the outpatient clinic of a university hospital showed that, among the 220 regular hypertensive patients, i.e. patients who attended the consultations within 30 days of the previously scheduled date for their return, 200 (90.9%) said they were taking the medication according to prescription (6) .
We also point out that, despite the great geographical distance between rural areas and health services reported by participants in our study, no association was found between the difficulty of access and non-adherence, which can be explained by the service provided by rural FHS. This team is present once a week in each village and, in all of them, there is a health center with daily presence of the community agent and nursing assistant, enabling, even incipiently, contact with the health service. Even with a number of difficulties in the political-administrative and financial context, the great expansion of primary health care in Brazil through the FHS has caused a positive impact on the health status and general health of the population (23) .
According to the World Health Organization (1) , however, age, gender, education, occupation, marital status, religion, ethnicity and urban versus rural life have not been associated with permanent adherence. Some authors (16) reported that non-adherence to treatment of SAH is more closely related to non-recognition of disease problems, to being asymptomatic than the difficulty of access to health services, a fact also observed in this study.
Conclusion
Our findings revealed high rates of non-adherence to medication treatment of SAH in urban and rural areas,
with the more significant rates in the urban population. 
